Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 188.88B P/E 33.02 EPS this Y 5.00% Ern Qtrly Grth -5.30%
Income 5.54B Forward P/E 23.51 EPS next Y 10.30% 50D Avg Chg 2.00%
Sales 40.73B PEG 2.97 EPS past 5Y 7.17% 200D Avg Chg 3.00%
Dividend 2.00% Price/Book 5.10 EPS next 5Y 8.20% 52W High Chg -6.00%
Recommedations 2.00 Quick Ratio 1.02 Shares Outstanding 1.74B 52W Low Chg 16.00%
Insider Own 0.53% ROA 6.26% Shares Float 1.73B Beta 0.72
Inst Own 77.49% ROE 14.44% Shares Shorted/Prior 13.36M/12.68M Price 108.62
Gross Margin 55.48% Profit Margin 13.65% Avg. Volume 4,711,008 Target Price 124.53
Oper. Margin 17.66% Earnings Date Oct 16 Volume 4,699,325 Change -1.73%
About Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Abbott Laboratories News
12/05/24 Abbott (ABT) Registers a Bigger Fall Than the Market: Important Facts to Note
12/05/24 Brokers Suggest Investing in Abbott (ABT): Read This Before Placing a Bet
12/05/24 Returns At Abbott Laboratories (NYSE:ABT) Are On The Way Up
12/04/24 Here is What to Know Beyond Why Abbott Laboratories (ABT) is a Trending Stock
11/29/24 Abbott (ABT) Stock Declines While Market Improves: Some Information for Investors
11/29/24 Growing EPD Business Supports ABT Stock Amid Macroeconomic Issues
11/29/24 Estimating The Intrinsic Value Of Abbott Laboratories (NYSE:ABT)
11/29/24 The Zacks Analyst Blog Abbott, BlackRock, ConocoPhillips, NetSol and Optex Systems
11/27/24 Top Research Reports for Abbott, BlackRock & ConocoPhillips
11/25/24 InspireMD Announces Appointment of Accomplished Medical Technology Executive Scott R. Ward to its Board of Directors
11/25/24 Abbott Announces First Step Toward Its Software-Guided Balloon-Expandable TAVI System to Treat Aortic Stenosis
11/24/24 Abbott Laboratories (NYSE:ABT) is largely controlled by institutional shareholders who own 78% of the company
11/22/24 2 Dividend Kings to Buy for a Lifetime of Passive Income
11/21/24 Major companies that are also popular short-selling stocks
11/20/24 Is Trending Stock Abbott Laboratories (ABT) a Buy Now?
11/19/24 Wall Street Bulls Look Optimistic About Abbott (ABT): Should You Buy?
11/18/24 Inside a $400 billion bet on the brain-computer interface revolution
11/16/24 Abbott Laboratories (ABT): A Magnificent Dividend Growth Stock to Buy Now
11/14/24 3 Ultra-Safe Dividend Stocks That Have Been Paying Dividends for More Than 100 Years
11/13/24 US transcatheter tricuspid valve repair market grows by over 50% since launch in Q2 2024
ABT Chatroom

User Image BlueStone19 Posted - 1 day ago

$ABT

User Image iQuicky Posted - 2 days ago

$ABT back in

User Image OptionSamurai Posted - 2 days ago

$ABT appears in our scan that looks for calls that will explode if the stock goes to analyst target. Analysts rating is BUY and the target price is 13.5% away📈. Call 125.0, 21-Feb-25 has: Max loss of 1.2% compared to holding shares and Breakeven is 9.2% away. If the stock hits the target, the call will profit 358% 🔥🔥🔥. 👉 Create your own scan here: https://bit.ly/3lR1xIP

User Image Stocksrunner Posted - 3 days ago

$ABT underperforming the nasdaq but analysts still bullish—maybe it's time to keep an eye on abbot's long-term potential. patience might pay off here. https://stocksrunner.com/symbol/ABT

User Image scottybebs Posted - 4 days ago

$ABT just can never get past $120

User Image Pitbowl Posted - 11/30/24

$AMGN $ABT $BAX $ABBV $MRMD

User Image Pitbowl Posted - 11/29/24

$AMGN $ABT $BAX $ABBV $MRMD

User Image TickerDD_com Posted - 11/29/24

How much is $ABT Shorted What is Short Interest for ABT As of October 31 2024 Settlement Date https://youtu.be/0rq66vNw5YY

User Image ClearVision353 Posted - 11/28/24

$ABT $MPWR $GOOG 🚨 PR ALERT 🚨 Top Stock to Watch on Friday. Check what’s happening with MYNZ 26% in 2 days, it’s moving !!! Jump on board !!! 😏🙏🚀 no RS, no delisting, FOMO hitting. TMO Healthcare Giant + 30M Offering Deal it’s going to the moon 🚀🔥💥 Tomorrow gonna be interesting…

User Image BlueStone19 Posted - 11/27/24

$ABT

User Image Hugs4Pugs4Ever Posted - 11/27/24

Long $ABT

User Image iBoughtTheWrongTicker Posted - 11/27/24

$ABT nice pop finally. On deck 122 next month!

User Image OptionSamurai Posted - 11/27/24

$ABT appears in our scan that looks for calls that will explode if the stock goes to analyst target. ✔ Analysts rating is BUY ✔ The analyst target price is 9.4% away ✔ IV Percentile is 12.3% Call 125.0, 17-Jan-25 has: 💀 Max loss of 1.1% compared to holding shares ⚖ Breakeven is 5.2% away 📈 If the stock hits the target, the call will profit 378% 🔥 See more results & create your own scan here: https://bit.ly/3lR1xIP

User Image Pitbowl Posted - 11/27/24

$AMGN $ABT $BAX $ABBV

User Image Pitbowl Posted - 11/26/24

$ABT $ABBV $AMGN $BAX $MRMD Pathway to Medical Cannabis: Prohibition to Prescription ✔️ 1. DEA removes cannabis from Schedule 1. 2. FDA studies cannabis for medical use. 3. Hospitals and pharmacies administer medical cannabis. 4. Insurance companies cover co-pays for patients. 5. Licensed medical cannabis companies sell to hospitals and pharmacies. 6. Shareholders benefit from medical cannabis stocks. 7. Dividends are administered.

User Image Article_AI Posted - 11/26/24

$ABT The Best Large-Cap Stocks to Buy Large-cap stocks are key additions to any well-rounded portfolio, but how do you find the best ones? We take a closer look here. https://www.stck.pro/news/ABT/94343576/

User Image Pitbowl Posted - 11/24/24

Loophole Alert: How Companies Sell THCa Online Without a License. $MRMD A surprising legal gap in the 2018 Farm Bill is reshaping online cannabis sales. THCa products are being sold legally online—no cannabis license required—as long as they test under 0.3% Delta-9 THC (dry weight). But here’s the catch: while THCa is non-psychoactive, it turns into Delta-9 THC when heated, delivering the same psychoactive effects as traditional cannabis. What’s Happening: - No License Needed: THCa products meet federal THC limits, sidestepping strict state laws. - Consumer Access: Buyers can order potent THCa products online without visiting a dispensary. Why It Matters: -This loophole highlights how regulations designed for hemp are unintentionally fueling a de facto cannabis market online, allowing consumers to access psychoactive products outside of state controls For more insights: r/CultoftheFranklin $ABT $ABBV $AMGN $BAX

User Image Pitbowl Posted - 11/24/24

$ABT $ABBV $AMGN $BAX

User Image JInvestTrade Posted - 11/24/24

$SENS need to bring awareness of this product. It solves a lot of the issues other CGM currently have. This would be a great SUPER BOWL ad. $SENS Other CGM $DXCM $ABT last no more than 14 days at best. Sometimes they last 2-5 days. They give false low reading (compression low) if you lay on it. They can be knock off and it would require a whole new sensor.

User Image JInvestTrade Posted - 11/24/24

$SENS $DXCM $ABT $TNDM $PODD A great interview with $SENS marketing person on the technology, advantage over other CGM, procedure of $SENS 365 and convenience. https://youtu.be/bT4IU8arLT8?feature=shared

User Image JInvestTrade Posted - 11/23/24

$SENS $DXCM $PODD $ABT $TNDM

User Image ezcmezwent Posted - 11/23/24

$ABT Here we go

User Image Pitbowl Posted - 11/23/24

$ABT $ABBV $AMGN $BAX 🤗

User Image MakingMeMeoutofME Posted - 11/23/24

$MDT acquired Fortimedix robotics noninvasive surgery company from Netherlands yesterday. revenue based company but not moving the needle tuck ins on the move for consistence beating and raising estimates back to 136 $BSX $ABT $SYK traders Medtornic is in a show me phase per the CEO. He bought back 4 billion in stock in 2 qtrs. He calling for 8-10% EPS growth. 15.6x vs 30xs - keep on watch as upgrades could be abound

User Image MakingMeMeoutofME Posted - 11/22/24

$MDT running on Monday on upgrade or new coverage $BSX $SYK $ABT traders welcome to join 15.7x eps and growing 10% eps year over year

User Image MakingMeMeoutofME Posted - 11/22/24

$MDT 85.40 ready to storm to new highs on 10% EPS growth Q3 over Q2 just reported and Q4 is 1.61 per share estimate or11-12% growth $BSX $ABT $SYK traders get on board at 15.5x pe 100 stock

User Image Article_AI Posted - 11/22/24

$ABT 2 Dividend Kings to Buy for a Lifetime of Passive Income 2 Dividend Kings to Buy for a Lifetime of Passive Income https://www.stck.pro/news/ABT/93909179/

User Image smartkarma Posted - 11/22/24

$ABT | Abbott Laboratories: A Tale Of Pipeline Productivity and Innovation! - Major Drivers "Abbott has demonstrated robust performance in its third quarter of 2024 with an organic sales growth of over 8%, excluding COVID testing sales,..." - Baptista Research (Baptista Research) Read more: https://www.smartkarma.com/insights/abbott-laboratories-a-tale-of-pipeline-productivity-and-innovation-major-drivers

User Image JackDarwin Posted - 11/21/24

$ABT Nice Bullish Engulfing Formed.

User Image JInvestTrade Posted - 11/21/24

$SENS $DXCM $TNDM $PODD $ABT

Analyst Ratings
Evercore ISI Group Outperform Oct 1, 24
Jefferies Hold Sep 26, 24
Piper Sandler Overweight Sep 19, 24
Jefferies Buy Aug 27, 24
Citigroup Buy Aug 22, 24
Barclays Overweight Jul 29, 24
Evercore ISI Group Outperform Jul 2, 24
RBC Capital Outperform Jun 4, 24
Goldman Sachs Buy May 30, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Wainer Andrea F EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Jan 29 Sell 112.5 42,500 4,781,250 65,027 01/31/24
Wainer Andrea F EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Jan 29 Option 52.17 42,500 2,217,225 82,527 01/31/24
Wainer Andrea F EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Dec 14 Sell 108 15,000 1,620,000 65,027 12/18/23
Wainer Andrea F EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Dec 14 Option 44.4 15,000 666,000 80,027 12/18/23
Wainer Andrea F EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Aug 08 Sell 105.95 10,400 1,101,880 65,027 08/10/23
Wainer Andrea F EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Aug 08 Option 38.4 5,000 192,000 75,427 08/10/23
STARKS DANIEL J Director Director Jul 27 Sell 113.72 50,000 5,686,000 6,775,316 07/28/23
Wainer Andrea F EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT May 02 Sell 110.56 8,226 909,467 70,427 05/03/23
Wainer Andrea F EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT May 02 Option 47 8,226 386,622 78,653 05/03/23
STARKS DANIEL J Director Director Apr 28 Sell 111.36 50,000 5,568,000 6,825,316 05/02/23
WOODGRIFT RANDEL WILLIAM SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT Feb 28 Sell 100.7 1,032 103,922 52,203 03/02/23
Morrone Louis H. SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT Feb 28 Sell 100.7 1,092 109,964 53,656 03/02/23
Moreland Mary K EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Feb 28 Sell 100.77 717 72,252 87,224 03/02/23
MANNING JOSEPH J EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Feb 28 Sell 100.7 1,339 134,837 62,323 03/02/23
Ginascol John F EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Feb 28 Sell 100.7 943 94,960 118,380 03/02/23
Funck, Jr. Robert E. EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Feb 28 Sell 100.7 1,264 127,285 218,237 03/02/23
Earnhardt Lisa D EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Feb 28 Sell 100.7 943 94,960 75,437 03/02/23
DALE MICHAEL D SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT Feb 28 Sell 100.7 1,209 121,746 45,133 03/02/23
ALLEN HUBERT L EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Feb 28 Sell 100.7 1,069 107,648 175,959 03/02/23
Ahlberg Gregory A SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT Feb 28 Sell 100.7 1,317 132,622 38,420 03/02/23
Karam Sammy SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT Dec 29 Sell 108.75 4,200 456,750 26,462 01/03/23
Ginascol John F EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Dec 13 Sell 112.32 11,000 1,235,520 111,912 12/15/22
STARKS DANIEL J Director Director Oct 27 Sell 97.72 50,000 4,886,000 6,873,500 10/31/22
MANNING JOSEPH J EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Sep 08 Option 44.4 23,008 1,021,555 76,253 09/09/22
MANNING JOSEPH J EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Sep 08 Sell 107 23,008 2,461,856 53,245 09/09/22
Ford Robert B CHAIRMAN AND CEO CHAIRMAN AND CEO Aug 25 Option 40.13 102,425 4,110,315 244,496 08/26/22
Ford Robert B CHAIRMAN AND CEO CHAIRMAN AND CEO Aug 25 Sell 105.1 102,425 10,764,868 142,071 08/26/22
MANNING JOSEPH J EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Aug 25 Option 44.4 23,008 1,021,555 80,143 08/26/22
MANNING JOSEPH J EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Aug 25 Sell 105.12 26,898 2,827,518 53,245 08/26/22
STARKS DANIEL J Director Director Jul 26 Sell 109.19 50,000 5,459,500 6,923,500 07/28/22
Mateus Fernando SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT Jul 26 Sell 109.0529 2,457 267,943 14,503 07/27/22
Tyler Julie L. SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT Jul 25 Sell 109.09 253 27,600 33,868 07/27/22
WOODGRIFT RANDEL WILLIAM SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT May 04 Option 44.4 24,000 1,065,600 71,854 05/05/22
WOODGRIFT RANDEL WILLIAM SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT May 04 Sell 113 24,000 2,712,000 47,854 05/05/22
STARKS DANIEL J Director Director May 03 Sell 113.55 50,000 5,677,500 6,973,500 05/05/22
DALE MICHAEL D SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT Mar 08 Sell 117.0003 4,000 468,001 41,780 03/10/22
WOODGRIFT RANDEL WILLIAM SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT Feb 28 Sell 118.1 964 113,848 49,223 03/02/22
Watkin Jared SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT Feb 28 Sell 118.1 1,038 122,588 66,545 03/02/22
Wainer Andrea F EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Feb 28 Sell 118.13 456 53,867 62,172 03/02/22
Salvadori Daniel Gesua Sive EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Feb 28 Sell 118.17 1,550 183,164 112,248 03/02/22
Morrone Louis H. SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT Feb 28 Sell 118.16 656 77,513 47,278 03/02/22
MANNING JOSEPH J EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Feb 28 Sell 118.16 779 92,047 60,873 03/02/22
Ginascol John F EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Feb 28 Sell 118.16 365 43,128 124,680 03/02/22
Earnhardt Lisa D EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Feb 28 Sell 118.15 943 111,415 90,630 03/02/22
DALE MICHAEL D SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT Feb 28 Sell 118.15 1,053 124,412 45,780 03/02/22
Calamari Christopher J. SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT Feb 28 Sell 118.15 706 83,414 25,658 03/02/22
ALLEN HUBERT L EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Feb 28 Sell 118.17 1,450 171,346 167,095 03/02/22
Ahlberg Gregory A SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT Feb 28 Sell 118.15 1,099 129,847 33,274 03/02/22
McKinstry Nancy Director Director Feb 24 Option 29.84 6,280 187,395 33,419 02/25/22
McKinstry Nancy Director Director Feb 24 Sell 116.43 1,614 187,918 31,805 02/25/22